This week in transparency news: April 18 – May 1, 2020

by Staff writer,
Posted on 5/1/2020

Clinical trial transparency in the pharmaceutical industry is continually evolving, and to stay on top of the news, TrialAssure brings a bi-weekly round-up of some of the key stories. Select recent and relevant stories are as follows:

DCRI-Led Registry Launches, Invites Healthcare Workers Nationwide to Fight COVID-19 Together – Duke Clinical Research Institute (DCRI)

The DCRI-led Healthcare Worker Exposure Response & Outcomes (HERO) Registry recently launched. The HERO registry encourages U.S. healthcare workers to share their experiences during the COVID-19 pandemic to better understand the problems faced by front line workers.

Read the full story

COVID-19 questions, modernization public meeting, and more: latest updates from ClinicalTrials.gov– ClinicalTrials.gov

ClinicalTrials.gov recently published three updates. The organization addressed two additional questions in its document “Responses to Top Questions from Responsible Parties Related to Coronavirus (COVID-19)” and has two updates regarding the ClinicalTrials.gov modernization project.

View all ClinicalTrials.gov news here

Former Gilead Sciences Head of Clinical Trial Transparency Disclosure and Data Transparency joins MMS and TrialAssure as Director of Global Transparency Strategy and Compliance—TrialAssure

Kelly Vaillant has been Director, Global Transparency Strategy and Compliance at MMS and TrialAssure. Vaillant will lead the transparency and compliance efforts across MMS and TrialAssure global operations.

Stay up to date with all TrialAssure news here

Share: